Metropolitan Life Insurance Company (MetLife)’s Cintas CTAS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,904	Closed	-$2.39M	–	522
2024 Q1	$2.39M	Sell	13,904 -196	-1%	-$30.2K	0.1%	169
2023 Q4	$2.12M	Sell	14,100 -216	-2%	-$28.9K	0.1%	175
2023 Q3	$1.72M	Sell	14,316 -756	-5%	-$94.1K	0.09%	190
2023 Q2	$1.87M	Sell	15,072 -384	-2%	-$45.1K	0.09%	189
2023 Q1	$1.79M	Sell	15,456 -4,040	-21%	-$445K	0.09%	198
2022 Q4	$2.2M	Sell	19,496 -656	-3%	-$71K	0.1%	201
2022 Q3	$1.96M	Sell	20,152 -468	-2%	-$47.8K	0.09%	213
2022 Q2	$1.93M	Sell	20,620 -808	-4%	-$78.7K	0.08%	226
2022 Q1	$2.28M	Sell	21,428 -33,644	-61%	-$3.27M	0.08%	229
2021 Q4	$6.1M	Sell	55,072 -1,036	-2%	-$112K	0.08%	189
2021 Q3	$5.34M	Sell	56,108 -2,620	-4%	-$256K	0.08%	199
2021 Q2	$5.61M	Sell	58,728 -700	-1%	-$62K	0.08%	195
2021 Q1	$5.07M	Sell	59,428 -3,256	-5%	-$276K	0.08%	206
2020 Q4	$5.54M	Sell	62,684 -1,780	-3%	-$155K	0.08%	188
2020 Q3	$5.36M	Sell	64,464 -1,376	-2%	-$106K	0.09%	175
2020 Q2	$4.38M	Buy	65,840 +424	+0.6%	+$24.5K	0.08%	204
2020 Q1	$2.83M	Sell	65,416 -644	-1%	-$42.1K	0.06%	274
2019 Q4	$4.44M	Buy	66,060 +52	+0.1%	+$3.42K	0.07%	233
2019 Q3	$4.42M	Sell	66,008 -1,220	-2%	-$78.1K	0.08%	230
2019 Q2	$3.99M	Buy	67,228 +3,412	+5%	+$189K	0.07%	250
2019 Q1	$3.22M	Sell	63,816 -3,920	-6%	-$190K	0.06%	274
2018 Q4	$2.84M	Sell	67,736 -72	-0.1%	-$3.22K	0.06%	280
2018 Q3	$3.35M	Sell	67,808 -1,740	-3%	-$89.9K	0.06%	279
2018 Q2	$3.22M	Buy	69,548 +764	+1%	+$34.4K	0.05%	298
2018 Q1	$2.93M	Buy	68,784 +660	+1%	+$27.4K	0.04%	333
2017 Q4	$2.65M	Sell	68,124 -108,708	-61%	-$4.13M	0.04%	376
2017 Q3	$6.38M	Sell	176,832 -3,984	-2%	-$133K	0.04%	439
2017 Q2	$5.7M	Sell	180,816 -3,384	-2%	-$105K	0.04%	493
2017 Q1	$5.83M	Sell	184,200 -2,364	-1%	-$70K	0.04%	490
2016 Q4	$5.39M	Sell	186,564 -4,088	-2%	-$115K	0.04%	525
2016 Q3	$5.37M	Sell	190,652 -4,776	-2%	-$131K	0.04%	486
2016 Q2	$4.79M	Sell	195,428 -4,008	-2%	-$92.3K	0.04%	540
2016 Q1	$4.48M	Sell	199,436 -2,404	-1%	-$51.6K	0.03%	567
2015 Q4	$4.59M	Sell	201,840 -7,720	-4%	-$176K	0.04%	535
2015 Q3	$4.49M	Sell	209,560 -15,340	-7%	-$329K	0.03%	553
2015 Q2	$4.76M	Sell	224,900 -1,672	-0.7%	-$35.1K	0.03%	573
2015 Q1	$4.62M	Sell	226,572 -2,252	-1%	-$45.7K	0.03%	556
2014 Q4	$4.49M	Buy	228,824 +68	+0%	+$1.23K	0.03%	594
2014 Q3	$4.04M	Sell	228,756 -12,980	-5%	-$211K	0.03%	618
2014 Q2	$3.84M	Sell	241,736 -2,700	-1%	-$40.8K	0.03%	672
2014 Q1	$3.64M	Sell	244,436 -4,012	-2%	-$59.3K	0.03%	694
2013 Q4	$3.7M	Sell	248,448 -9,840	-4%	-$134K	0.03%	667
2013 Q3	$3.31M	Sell	258,288 -4,884	-2%	-$59.3K	0.03%	669
2013 Q2	$3M	Buy	+263,172	New	+$2.97M	0.02%	688

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTAS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cintas (CTAS) in Q2 2024, closing a stake of 13,904 shares — an estimated $2.39M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTAS in Q2 2013 and held it in 44 quarters. The position peaked at $6.38M in Q3 2017. 1,268 funds tracked by Wall St. Rank hold CTAS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Cintas position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 13,904 Cintas shares in Q2 2024, an estimated $2.39M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Cintas in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Cintas position peaked at $6.38M in Q3 2017.
1,268 funds tracked by Wall St. Rank held Cintas as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.